Interleukin-8 administration enhances venous thrombosis resolution in a rat model

Area of Science:

• Vascular Biology
• Inflammation Research
• Thrombosis Studies

Background:

• Limited therapeutic options exist for deep vein thrombosis (DVT) resolution when anticoagulation is contraindicated or complicated.
• Thrombus maturation involves neutrophil influx and neovascularization, suggesting potential therapeutic targets.

Purpose of the Study:

• To investigate if administering the chemokine interleukin-8 (IL-8) could accelerate DVT resolution.
• To explore the role of IL-8 in thrombus neovascularization and inflammatory cell infiltration.

Main Methods:

• A rodent model of DVT was established using inferior vena cava (IVC) ligation.
• Daily intravenous administration of recombinant human IL-8 or vehicle control.
• Analysis included duplex ultrasound, venous pressure measurements, immunohistochemistry for neutrophils (PMN) and monocytes, chemokine analysis, and fibrosis assessment.

Main Results:

• IL-8 significantly accelerated thrombus dissolution at 4 days, indicated by increased blood flow and venous pressure.
• IL-8 treatment led to greater thrombus neovascularization and increased PMN infiltration at 4 days.
• Fibrosis was significantly increased at 8 days post-IL-8 treatment, suggesting enhanced resolution.

Conclusions:

• A proinflammatory and proangiogenic milieu induced by IL-8 enhances thrombus resolution.
• The findings highlight the critical relationship between neovascularity, inflammation, and DVT resolution.